Sell tickets with Eventfinda TixSuite. No per-ticket fees. Try it for free today!

Australian Dementia Research Forum 2024

Ticket Information

  • Full conference- Early bird (Medical Professionals): $880.00 each
  • Full conference- Early bird (Researcher, Registrar, Allied Health Practitioner, Nurse, Academia),: $715.00 each
  • Full conference- Early bird (Persons living with dementia or mild cognitive impairment and carers): $220.00 each
  • Full conference- Early bird (Students): $330.00 each
  • One Day Registration (any day) - Early Bird: $440.00 each
  • Continuing Education (1 day only) - Early Bird: $440.00 each
  • Full conference -Virtual Registration - Early Bird: $220.00 each
  • Full conference -Virtual Registration- persons living with dementia or mild cognitive impairment: $165.00 each
  • Buy Tickets
  • Additional fees may apply

Dates

  • Mon 3 Jun 2024, 9:00am–6:00pm
  • Tue 4 Jun 2024, 9:00am–6:00pm
  • Wed 5 Jun 2024, 9:00am–6:00pm

Restrictions

18+

Listed by

matylda

The Australian Dementia Research Forum is the premier annual event that brings together dementia researchers, health professionals and policy makers, as well as people living with dementia and their families and carers, to discuss the latest research, innovations, and best practices in dementia. Following the success of last year’s conference, we are pleased to announce that this year’s Forum (ADRF2024) will again be held in person on the sunny Gold Coast, Queensland from 3rd to 5th June.

The theme for the ADRF2024 is Turning the Tide on Dementia, with particular focus on exciting new innovations in the field. The Forum is a meeting place for national and global experts to share the latest developments in dementia research, care and policy and to challenge perceptions of living with, or caring for someone with, a dementia diagnosis.

Five expert international and national speakers have been invited to deliver keynote addresses at ADRF2024, on topics spanning monoclonal antibodies, exercise physiology, neuroimaging, molecular causes of tauopathy in Alzheimer’s disease and dementia prevalence in specific communities. This year for the first time we specifically highlight the work and warmly welcome our colleagues in Asia and New Zealand to feature as a key part of the program.

​For a second consecutive year, our Continuing Education professional development sessions for medical, health and care practitioners will be on offer. Held on Day 1 of the Forum, topics will include risk reduction, pathways for care, deprescribing, post-diagnostic support, and anti-amyloid therapies.

Post a comment

Are you going to this event, or would you like to? Let the community know what you're looking forward to most by posting your comments here!